CergenX is an innovative brand that specializes in cutting-edge technology for the analysis of baby brain waves. Their advanced technology allows for the early identification of brain injuries in newborn infants, enabling timely interventions and improved outcomes. Using artificial intelligence, CergenX aims to identify infants who are at the highest risk of brain injury, helping to make a real difference in their lives.

Formed by a group of scientists and software engineers, CergenX utilizes recent advances in AI to revolutionize neonatal brain monitoring technology. It is a spin-out from the INFANT Research Centre at University College Cork, benefiting from the expertise of Professor Geraldine Boylan, a renowned expert in neonatal physiology. The success and impact of CergenX's groundbreaking solutions have been recognized in recent news articles, with the company securing additional funding for its AI-based baby brain scanning software.

CergenX's mission to ensure better brain health for all babies is made possible through their dedication to innovation and their commitment to early detection and intervention. If you're interested in learning more or getting in touch, CergenX welcomes you to reach out through their website. Join CergenX in their quest to make a difference in the lives of newborns and revolutionize neonatal brain monitoring through state-of-the-art technology